-- A strike or other work stoppage, or the inability to renew collective
bargaining agreements on favorable terms, could have a material adverse
effect on the cost structure and operational capabilities of AFC.
-- The pharmaceutical fine chemicals industry is a capital-intensive
industry and if AFC does not have sufficient financial resources to
finance the necessary capital expenditures, its business and results of
operations may be harmed.
-- We may be subject to potential product liability claims that could
affect our earnings and financial condition and harm our reputation.
-- Technology innovations in the markets that we serve may create
alternatives to our products and result in reduced sales.
-- We are subject to competition in certain industries where we
participate and therefore may not be able to compete successfully.
-- Due to the nature of our business, our sales levels may fluctuate
causing our quarterly operating results to fluctuate.
-- The volatility of the chemical industry affects our capacity
utilization and causes fluctuations in our results of operations.
-- A loss of key personnel or highly skilled employees could disrupt our
-- We may continue to expand our operations through acquisitions, which
could divert management's attention and expose us to unanticipated
liabilities and costs. We may experience difficulties integrating the
acquired operations, and we may incur costs relating to acquisitions
that are never consummated.
-- We have a substantial amount of debt, and the cost of servicing that
debt could adversely affect our ability to take actions, our liquidity
or our financial condition.
-- If we are unable to generate sufficient cash flow to service our debt
and fund ou
|SOURCE American Pacific Corporation|
Copyright©2008 PR Newswire.
All rights reserved